《全日總結》恆指升49點 藥明生物彈一成 晶片股揚
美股三大指數續創歷史新高,港股今日反覆造好。恆指高開189點後升幅收窄,中午前低見24,678點倒跌85點,午後再度上升,全日升49點或0.2%,收24,813點;國指升12點或0.14%,收8,806點;恆生科技指數升27點或0.45%,收6,221點。大市全日成交總額縮減至985.74億元,爲半年新低,滬、深港通南下交易分別淨流入3.63億及3.92億元人民幣。
科技股方面,騰訊(00700.HK)升不足0.1%報464元,阿裏巴巴(09988.HK)跌0.1%報157.1元,美團(03690.HK)跌0.3%報270.4元。小米(01810.HK)平收報20.35元,京東(09618.HK)及快手(01024.HK)各跌1.3%及1.4%,百度(09888.HK)升1%。
此外,京東健康(06618.HK)升6%,平安好醫生(01833.HK)、閱文(00772.HK)及阿裏健康(00241.HK)各升2.6%至3.3%。手機相關股比亞迪電子(00285.HK)及鴻騰(06088.HK)各升3.6%及3.8%,舜宇(02382.HK)跌1.9%報202元。晶片股中芯(00981.HK)及華虹半導體(01347.HK)各升3.9%及4%。
中國恆大(03333.HK)沽2億股恆騰網絡(00136.HK)套現4.1億,中國恆大升0.9%報2.3元,恆騰昇4.9%報2.15元。同系恆大物業(06666.HK)及恆大汽車(00708.HK)各升2.4%及4.1%。其他內房股普遍下跌,世茂(00813.HK)及富力(02777.HK)各跌7%及5.3%,碧桂園(02007.HK)及旭輝(00884.HK)各跌5%及4.1%,合景泰富(01813.HK)跌3.3%。奧園系奧園(03883.HK)及奧園健康(03662.HK)各反彈1.9%及5%。
醫藥股藥明生物(02269.HK)及開拓藥業(09939.HK)各反彈10.2%及22.4%,信達生物(01801.HK)升8.1%。
內需股海底撈(06862.HK)及統一企業中國(00220.HK)各跌5.4%,中國旺旺(00151.HK)跌2.7%。體育用品股特步(01368.HK)升6.3%,安踏(02020.HK)及李寧(02331.HK)各升3.6%及2.3%。
其他藍籌股方面,匯控(00005.HK)跌0.3%報45.55元,港交所(00388.HK)跌0.4%報465元,友邦(01299.HK)跌0.6%報85.6元,中移動(00941.HK)跌0.3%報48.1元。消息指兩電明年電費加幅6%至7%,中電(00002.HK)及港燈(02638.HK)各升0.3%及1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.